Medicare Enrolled

Dr. Carmen Dohmeier, M.D.

Neurology · Greensboro, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
912 THIRD STREET, Greensboro, NC 27405
3362732511
In practice since 2006 (20 years)
NPI: 1588620066 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dohmeier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dohmeier? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dohmeier

Dr. Carmen Dohmeier is a neurology specialist in Greensboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dohmeier performed 301 Medicare services across 280 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dohmeier received a total of $11,458 from 89 pharmaceutical and/or device companies across 504 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dohmeier is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 301 Medicare services $11,458 industry payments

Medicare Practice Summary

Medicare Utilization ↗
301
Medicare services
Bottom 42% in NC for neurology
280
Unique beneficiaries
$136
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
81 $86 $260
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
70 $58 $175
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
40 $103 $645
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
37 $104 $395
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $118 $350
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
22 $468 $1,900
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
18 $443 $1,825
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,458
Total received (2018-2024)
Avg $1,637/year across 7 years
Top 20% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
504
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,458 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,130
2023
$3,024
2022
$835
2021
$583
2020
$366
2019
$2,041
2018
$1,481

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$687
ABBVIE INC.
$307
UCB, Inc.
$270
Biogen, Inc.
$199
Neurelis, Inc.
$189
Novartis Pharmaceuticals Corporation
$137
Lundbeck LLC
$137
E.R. Squibb & Sons, L.L.C.
$122
Alexion Pharmaceuticals, Inc.
$106
Celgene Corporation
$99
TG Therapeutics, Inc.
$95
ARGENX US, INC.
$67
JAZZ PHARMACEUTICALS INC.
$65
PFIZER INC.
$63
Vanda Pharmaceuticals Inc.
$45
Avadel CNS Pharmaceuticals, LLC
$42
Amgen Inc.
$40
Genentech USA, Inc.
$39
Eisai Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$34
Boston Scientific Corporation
$32
ACADIA Pharmaceuticals Inc
$28
BANNER LIFE SCIENCES, LLC
$28
HARMONY BIOSCIENCES LLC
$27
Novo Nordisk Inc
$27
MDD US Operations, LLC
$23
Teva Pharmaceuticals USA, Inc.
$22
Neurocrine Biosciences, Inc.
$20
Axsome Therapeutics, Inc.
$18
CSL Behring
$17
SCILEX PHARMACEUTICALS INC.
$17
Mallinckrodt Hospital Products Inc.
$17
Otsuka America Pharmaceutical, Inc.
$16
Lilly USA, LLC
$16
Acorda Therapeutics, Inc
$15
Merz Pharmaceuticals, LLC
$15
SK Life Science, Inc.
$13
Top 3 companies account for 40.4% of 2024 payments
All-time payments by company (2018-2024) ›
Inspire Medical Systems, Inc.
$1,254
EMD Serono, Inc.
$1,042
Biogen, Inc.
$744
Novartis Pharmaceuticals Corporation
$625
UCB, Inc.
$536
Amgen Inc.
$513
ABBVIE INC.
$442
Teva Pharmaceuticals USA, Inc.
$382
JAZZ PHARMACEUTICALS INC.
$344
GENZYME CORPORATION
$268
Lundbeck LLC
$257
Neurelis, Inc.
$257
E.R. Squibb & Sons, L.L.C.
$228
Alexion Pharmaceuticals, Inc.
$221
AbbVie Inc.
$206
Harmony Biosciences LLC
$205
Celgene Corporation
$184
HARMONY BIOSCIENCES LLC
$172
Lilly USA, LLC
$168
ACADIA Pharmaceuticals Inc
$148
Greenwich Biosciences, Inc.
$141
Adamas Pharmaceuticals, Inc.
$138
CSL Behring
$129
Acorda Therapeutics, Inc
$128
ARGENX US, INC.
$102
LivaNova USA, Inc.
$101
Allergan Inc.
$101
GE HEALTHCARE
$99
TG Therapeutics, Inc.
$95
Axsome Therapeutics, Inc.
$90
Medtronic, Inc.
$86
Amneal Pharmaceuticals LLC
$82
Otsuka America Pharmaceutical, Inc.
$80
PFIZER INC.
$76
Mitsubishi Tanabe Pharma America, Inc.
$76
Philips Electronics North America Corporation
$76
Genentech USA, Inc.
$75
Neurocrine Biosciences, Inc.
$68
Avion Pharmaceuticals
$64
Akcea Therapeutics, Inc.
$63
Vanda Pharmaceuticals Inc.
$62
Merz North America, Inc.
$59
Eisai Inc.
$50
SK Life Science, Inc.
$49
Boston Scientific Corporation
$48
Jazz Pharmaceuticals Inc.
$46
TG THERAPEUTICS, INC.
$46
Merz Pharmaceuticals, LLC
$44
Mallinckrodt LLC
$44
GRT US Holding, Inc.
$43
Regeneron Healthcare Solutions, Inc.
$43
SANOFI-AVENTIS U.S. LLC
$42
Avadel CNS Pharmaceuticals, LLC
$42
Sunovion Pharmaceuticals Inc.
$41
BANNER LIFE SCIENCES, LLC
$41
Allergan, Inc.
$40
Mallinckrodt Hospital Products Inc.
$38
Corium, LLC
$34
Takeda Pharmaceuticals U.S.A., Inc.
$34
Avanir Pharmaceuticals, Inc.
$28
Novo Nordisk Inc
$27
Ipsen Biopharmaceuticals, Inc
$27
GE Healthcare
$26
US WorldMeds, LLC
$25
MDD US Operations, LLC
$23
Strongbridge US INC.
$23
MERZ NORTH AMERICA, INC.
$21
Microtransponder, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
EISAI INC.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$19
Mallinckrodt Enterprises LLC
$18
Sandoz Inc.
$17
Grifols USA, LLC
$17
SCILEX PHARMACEUTICALS INC.
$17
Collegium Pharmaceutical, Inc.
$16
Supernus Pharmaceuticals, Inc.
$15
Kyowa Kirin, Inc.
$15
Mylan Pharmaceuticals Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Exeltis, USA Inc.
$14
UPSHER-SMITH LABORATORIES LLC
$14
Resmed Corp
$14
Vertical Pharmaceuticals, LLC
$14
ARBOR PHARMACEUTICALS, INC.
$14
Alnylam Pharmaceuticals Inc.
$13
IMPEL PHARMACEUTICALS INC.
$13
Assertio Therapeutics, Inc.
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 26.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · AirCurve · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · COPAXONE · DS Cpap Auto Core · DUOPA · DYSPORT · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Fycompa · GENERAL - PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · INTELLIS ADAPTIVESTIM · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCREVUS · ONPATTRO · Ocrevus · PANZYGA · POMPE - DISEASE · PONVORY · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PURIFIED CORTROPHIN GEL · QULIPTA · Qutenza · RADICAVA · RELEXXII · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · Soliris · Sunosi · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trilogy 100 · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · Wegovy · XEOMIN · XLSD · XYREM · XYWAV · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Greensboro?
Compare neurologists in the Greensboro area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
33
Per 100K population
6.1
County median income
$66,027
Nearest hospital
MOSES H. CONE MEMORIAL HOSPITAL, THE
3.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dohmeier is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dohmeier experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dohmeier performed 81 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dohmeier receive payments from pharmaceutical companies?
Yes. Dr. Dohmeier received a total of $11,458 from 89 companies across 504 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dohmeier's costs compare to other neurologists in Greensboro?
Dr. Dohmeier's average Medicare payment per service is $136. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dohmeier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →